John Zuris

John Zuris

Company: Editas Medicine

Job title: Director


Workshop Leaders: 9:00 am

This workshop will cover: Reviewing and comparing the leading techniques such as CRISPR/Cas9, TALENS, Transposases or Landing Pad with recombinases and their suitability for gene engineering and integration of large payloads Evaluating how the use of either target integration or random integration affects the timeline of advanced therapies Comparing how each approach to cell line…Read more

day: Pre-Conference Workshop Day

Achieving Extremely Efficient Transgene Insertion to Gain Control of Expression 12:00 pm

Using Sleek technology to increase the efficiency of gene knock-in via CRISPR Harnessing the security and promoter strength of essential genes to gain control over expression Reducing off target effects and variable yields with precise gene insertionRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.